Detailed Product Description

Taking the most advanced influenza producing technology, virus splitting, purification, control tests and specifications are in accordance with WHO standard.

  Good vaccine quality, satisfied immunity results, ideal immnunogenicity, high seroconversion rate, anti-body increasing time, all are above the standards set by European Union.

Special advise: the vaccine should be injected annually.

1. For adult use in vial and persons aged above 3.

2. For adult use in pre-filled syringe and persons aged above 3.

3. For paediatric use in vial aged between 6 months and 35 months.

4. For paediatric use in pre-filled-syringe aged between 6 months and 35 months.